跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,970 条关于
“Wells Fargo Securities”
全部
9,970
临床试验
7,551
药物
1,259
机构
32
资讯
1,128
8个月前
Anteris Technologies Raises $200 Million to Advance Aortic Stenosis Treatment with Strategic Medtronic Partnership
9个月前
Medtronic Files IPO Registration for Diabetes Business MiniMed, Targeting Nasdaq Listing
去年
Kestra Medical Technologies Launches IPO, Aims to Raise $140-160 Million for Cardiovascular Wearable Technology
9个月前
Kymera Therapeutics Closes Upsized $602 Million Public Offering to Advance Targeted Protein Degradation Pipeline
去年
Intellia Therapeutics Price Target Lowered by Wells Fargo
去年
Mineralys Therapeutics Secures $175 Million in Public Offering to Advance Aldosterone Inhibitor for Cardiorenal Diseases
去年
Wells Fargo Lowers Intellia Therapeutics Price Target to $60
去年
Sutro Biopharma Appoints Greg Chow as CFO to Advance ADC Pipeline
去年
Acelyrin's Izo Fails Phase 2b/3 Trial in Uveitis; Wells Fargo Adjusts Price Target
9个月前
Alumis Raises $300 Million in Public Offering Following Planned ACELYRIN Merger
第 1 页,共 113 页
上一页
下一页